iCAD Inc (ICAD) - Financial and Strategic SWOT Analysis Review

iCAD Inc (ICAD) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDME232FSA
  • |
  • Pages: 54
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

iCAD Inc (ICAD)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


iCAD Inc (iCAD) develops and markets computer aided detection (CAD) solutions and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD products find application in detection and treatment of breast, prostate and colorectal cancers. The company markets products through direct sales organization, OEM partners, distributors and resellers. The company has manufacturing facility in New Hampshire and an operation, manufacturing, warehouse, research and development facility in San Jose, California. The company operates primarily in the US and it also exports products to various countries in Europe and Asia. iCAD is headquartered in Nashua, New Hampshire, the US.

iCAD Inc Key Recent Developments

Aug 29,2018: iCAD Announces AERB Approval of Xoft System in India

Aug 28,2018: Medical City Plano, a HCA Healthcare Facility, Adopts iCADs Xoft Electronic Brachytherapy System for Treatment of Early-Stage Breast Cancer

Aug 14,2018: iCAD reports second quarter 2018 financial results

May 14,2018: iCAD Announces First Quarter 2018 Financial Results

Mar 22,2018: iCAD Announces Fourth Quarter And Full-Year 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

iCAD Inc-Key Facts 6

iCAD Inc-Key Employees 7

iCAD Inc-Key Employee Biographies 8

iCAD Inc-Major Products and Services 9

iCAD Inc-History 10

iCAD Inc-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

iCAD Inc-Business Description 15

Business Segment: Cancer Detection (Detection) 15

Overview 15

Performance 15

Business Segment: Cancer Therapy (Therapy) 15

Overview 15

Performance 15

R&D Overview 16

iCAD Inc-Corporate Strategy 17

iCAD Inc-SWOT Analysis 18

SWOT Analysis-Overview 18

iCAD Inc-Strengths 18

iCAD Inc-Weaknesses 19

iCAD Inc-Opportunities 20

iCAD Inc-Threats 21

iCAD Inc-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

iCAD Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 30

iCAD Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 31

iCAD Inc, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

Aug 14, 2018: iCAD reports second quarter 2018 financial results 33

May 14, 2018: iCAD Announces First Quarter 2018 Financial Results 36

Mar 22, 2018: iCAD Announces Fourth Quarter And Full-Year 2017 Financial Results 38

Feb 08, 2018: iCAD Named a Top Artificial Intelligence Medical Imaging Solution Provider by Healthcare Tech Outlook 40

Nov 27, 2017: iCAD's PowerLook Tomo Detection Experiences Growing Adoption 41

Nov 08, 2017: iCAD Reports Third Quarter 2017 Financial Results 42

Aug 08, 2017: iCAD Reports Second Quarter 2017 Financial Results and Announces USD 13 Million Credit Facility With Silicon Valley Bank 44

May 02, 2017: iCAD Reports First-quarter 2017 Financial Results 46

Mar 08, 2017: iCAD Reports Fourth Quarter and Full Year 2016 Financial Results 48

Section 6-Appendix 50

Methodology 50

Ratio Definitions 50

About GlobalData 54

Contact Us 54

Disclaimer 54

List of Figures

iCAD Inc, Performance Chart (2013-2017) 27

iCAD Inc, Ratio Charts 29

iCAD Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 30

iCAD Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 31

List of Tables

iCAD Inc, Key Facts 6

iCAD Inc, Key Employees 7

iCAD Inc, Key Employee Biographies 8

iCAD Inc, Major Products and Services 9

iCAD Inc, History 10

iCAD Inc, Other Locations 13

iCAD Inc, Subsidiaries 13

iCAD Inc, Key Competitors 22

iCAD Inc, Ratios based on current share price 23

iCAD Inc, Annual Ratios 24

iCAD Inc, Annual Ratios (Cont...1) 25

iCAD Inc, Annual Ratios (Cont...2) 26

iCAD Inc, Interim Ratios 28

iCAD Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 30

iCAD Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 31

iCAD Inc, Recent Deals Summary 32

Currency Codes 50

Capital Market Ratios 50

Equity Ratios 51

Profitability Ratios 51

Cost Ratios 52

Liquidity Ratios 52

Leverage Ratios 53

Efficiency Ratios 53

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Siemens Medical Solutions USA Inc

Philips Healthcare

Merge Healthcare Inc

Hologic Inc

GE Healthcare LLC

Elekta Inc

iCAD Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com